These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15905110)

  • 1. Anticonvulsant activity and tolerance of ELB138 in dogs with epilepsy: a clinical pilot study.
    Rieck S; Rundfeldt C; Tipold A
    Vet J; 2006 Jul; 172(1):86-95. PubMed ID: 15905110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
    Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and/or potassium bromide.
    Chang Y; Mellor DJ; Anderson TJ
    J Small Anim Pract; 2006 Oct; 47(10):574-81. PubMed ID: 17004949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996).
    Trepanier LA; Van Schoick A; Schwark WS; Carrillo J
    J Am Vet Med Assoc; 1998 Nov; 213(10):1449-53. PubMed ID: 9828942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency.
    Stee K; Martlé V; Broeckx BJG; Royaux E; Van Ham L; Bhatti SFM
    Vet J; 2017 Dec; 230():1-5. PubMed ID: 29208209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of bromide in therapy resistant epilepsy of dogs].
    Schwartz-Porsche D; Jürgens U
    Tierarztl Prax; 1991 Aug; 19(4):395-401. PubMed ID: 1948987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.
    Neßler J; Rundfeldt C; Löscher W; Kostic D; Keefe T; Tipold A
    BMC Vet Res; 2017 Jan; 13(1):33. PubMed ID: 28118828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs.
    Tipold A; Keefe TJ; Löscher W; Rundfeldt C; de Vries F
    J Vet Pharmacol Ther; 2015 Apr; 38(2):160-8. PubMed ID: 25079881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant drugs used in the treatment of epilepsy.
    Frey HH
    Probl Vet Med; 1989; 1(4):558-77. PubMed ID: 2520134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin.
    Royaux E; Van Ham L; Broeckx BJ; Van Soens I; Gielen I; Deforce D; Bhatti SF
    Vet J; 2017 Feb; 220():51-54. PubMed ID: 28190495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veterinarians' preferences for anticonvulsant drugs for treating seizure disorders in dogs and cats.
    Kluger EK; Malik R; Govendir M
    Aust Vet J; 2009 Nov; 87(11):445-9. PubMed ID: 19857237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of gamma-vinyl-gamma-aminobutyric acid for control of epilepsy in dogs.
    Speciale J; Dayrell-Hart B; Steinberg SA
    J Am Vet Med Assoc; 1991 Mar; 198(6):995-1000. PubMed ID: 2032927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs.
    Boothe DM; Dewey C; Carpenter DM
    J Am Vet Med Assoc; 2012 May; 240(9):1073-83. PubMed ID: 22515627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of epilepsy of dogs and cats.
    LeCouteur RA; Child G
    Probl Vet Med; 1989; 1(4):578-95. PubMed ID: 2520135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical signs, risk factors, and outcomes associated with bromide toxicosis (bromism) in dogs with idiopathic epilepsy.
    Rossmeisl JH; Inzana KD
    J Am Vet Med Assoc; 2009 Jun; 234(11):1425-31. PubMed ID: 19480623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nimodipine for treatment of idiopathic epilepsy in dogs.
    O'Brien DP; Simpson ST; Longshore RC; Kroll RA; Goetze L
    J Am Vet Med Assoc; 1997 May; 210(9):1298-301. PubMed ID: 9143533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide monotherapy for idiopathic epilepsy in dogs.
    Chung JY; Hwang CY; Chae JS; Ahn JO; Kim TH; Seo KW; Lee SY; Youn HY
    N Z Vet J; 2012 Nov; 60(6):357-9. PubMed ID: 22639873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
    Farnbach GC
    J Am Vet Med Assoc; 1984 May; 184(9):1117-20. PubMed ID: 6725128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic serum concentrations of primidone and its metabolites, phenobarbital and phenylethylmalonamide in epileptic dogs.
    Cunningham JG; Haidukewych D; Jensen HA
    J Am Vet Med Assoc; 1983 May; 182(10):1091-4. PubMed ID: 6863121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic epilepsy in dogs and cats.
    Thomas WB
    Vet Clin North Am Small Anim Pract; 2010 Jan; 40(1):161-79. PubMed ID: 19942062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.